Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

102results about How to "Prevent and inhibit" patented technology

Method for reducing NOx during combustion of coal in a burner

An organically complexed nanocatalyst composition is applied to or mixed with coal prior to or upon introducing the coal into a coal burner in order to catalyze the removal of coal nitrogen from the coal and its conversion into nitrogen gas prior to combustion of the coal. This leads to reduced NOx production during coal combustion. The nanocatalyst compositions include a nanoparticle catalyst that is made using a dispersing agent. The dispersing agent includes at least one functional group such as a hydroxyl, a carboxyl, a carbonyl, an amine, an amide, a nitrile, a nitrogen having a free lone pair of electrons, an amino acid, a thiol, a sulfonic acid, a sulfonyl halide, and an. acyl halide. The dispersing agent forms stable, dispersed, nano-sized catalyst particles. The catalyst composition can be formed as a stable suspension to facilitate storage, transportation and application of the catalyst nanoparticles to a coal material. The catalyst composition can be applied before or after pulverizing the coal material or it may be injected directly into the coal burner together with pulverized coal.
Owner:HEADWATERS TECH INNOVATION GRP

Semiconductor Memory Devices

A semiconductor memory device may include: a stacking structure including a plurality of insulating layers and a plurality of gate electrodes alternately stacked on a substrate; a lower semiconductor pattern that protrudes from the top of the substrate; a vertical insulating pattern that extends in a vertical direction from the substrate and penetrates the stacking structure; and a vertical channel pattern on the inner surface of the vertical insulating pattern and contacting the lower semiconductor pattern, wherein an upper part of the lower semiconductor pattern includes a recess region including a curve-shaped profile, and in the recess region, the outer surface of a lower part of the vertical channel pattern contacts the lower semiconductor pattern along a curve of the recess region.
Owner:SAMSUNG ELECTRONICS CO LTD

Compositions for inhibiting macrophage activity

Use of an agent capable of inhibiting the interaction between SIRP1alpha and CD47, in the preparation of a composition for the inhibition of macrophage involvement in autoimmune disease. The invention further relates to a method for the treatment of an autoimmune disease with macrophage involvement, comprising administering to a mammal an effective amount of an agent which inhibits the interaction between CD47 and SIRP1alpha. The invention also relates to a method for identifying an agent capable of inhibiting the interaction between CD47 and SIRP1alpha, comprising the steps of exposing one or more test compounds to CD47 and / or SIRP1alpha, and monitoring the ability of the test compound to inhibit their interaction.
Owner:MEDICAL RESEARCH COUNCIL

Active material devices with containment layer

An active material electronic device is described with a containment layer. The device includes an active chalcogenide, pnictide, or phase-change material in electrical communication with an upper and lower electrode. The device includes a containment layer formed over the active material that prevents escape of volatilized matter from the active material when the device is exposed to high temperatures during fabrication or operation. The containment layer further prevents chemical contamination of the active material by protecting it from reactive species in the processing or ambient environment. The containment layer and intermediate layers formed between the active material and containment layer are formed at temperatures sufficiently low to prevent volatilization of the active material. Once the containment layer is formed, the device may be subjected to high temperature or chemically aggressive environments without impairing the compositional or structural integrity of the active material. Inclusion of the containment layer is shown to extend the cycle life of the device by over two orders of magnitude.
Owner:OVONYX MEMORY TECH LLC

Apparatus and method for forming 3D objects

A printer apparatus and a method for continuously printing a three-dimensional (3D) object. The printer apparatus has an elongated container for containing build fluid comprising a monomer from which the 3D object is made. A means for continuous conveying a build platform has a build surface that descending down into the build fluid. A matrix of light emitting elements are disposed above the elongated container, and emit a predetermined pattern of a reactive light toward the continuously conveyed build surface and at the upper surface of the build fluid. The reactive light has a predetermined pattern that polymerizes and / or agglomerates a portion of the upper surface of the build fluid into a build material having a build pattern comprising the build material. The build platform can have a plurality of build surface segments attached in series along a continuous conveyor.
Owner:STEELE WILLIAM J

Methods of treating autoimmune diseases with dll4 antagonists

The present invention provides methods of treating a disease or disorder, in which increasing the number of regulatory T cell (Treg) is beneficial, by administering to a subject suffering from such a disease or disorder a therapeutically effective amount of DII4 antagonists that block DII4-Notch signal pathways, thereby increasing the number of Treg. Diseases or disorders treatable by the methods of the invention include autoimmune diseases or disorders, such as multiple sclerosis (MS), diabetes, and the like. Suitable DII4 antagonists for the invention include antibodies or antibody fragments that specifically bind DII4 and block DII4-Notch interactions, the extracellular domain of DII4, and the like. The invention also provides methods of preventing an occurrence or recurrence of such diseases or disorders in a subject predisposed or susceptible to developing such diseases or disorders. Furthermore, the methods of the invention are useful in preventing or treating organ transplant rejections or graft-versus-host disease.
Owner:REGENERON PHARM INC

Use of Anti-pacap antibodies and antigen binding fragments thereof for treatment, prevention, or inhibition of photophobia

This invention relates to methods of screening for anti-PACAP antibodies, or anti-PACAP receptor antibodies, and antigen binding fragments thereof, for potential use in treating or preventing PACAP-associated photophobia or light aversion, and therapeutic compositions containing and methods of using anti-PACAP antibodies, or anti-PACAP receptor antibodies, and antigen binding fragments thereof.
Owner:ALDERBIO HLDG LLC +2

Engine

InactiveUS20100192887A1Increase friction lossUnexpected grow of friction loss can be inhibited or preventedLubrication of auxillariesValve drivesCylinder headEngineering
An oil recovery part (20A, 20B) for guiding oil to an inner side of a peripheral wall of a cylinder head (2) is provided at a front wall upper end of the cylinder head (2), the oil leaking from a concave bearing (3a, 3b) that supports a camshaft (8, 9) provided at a forefront end of a cam housing (3).
Owner:TOYOTA JIDOSHA KK

Controlled and Localized Release of Retinoids to Improve Neointimal Hyperplasia

InactiveUS20100036476A1Prevent or inhibitTreat, prevent, or inhibit thrombosis and neointimal hyperplasiaSurgeryAntithrombogenic treatmentLeiomyocyteNitric oxide
Controlled release vascular implants, such as vascular grafts, stents, wraps, and gels comprising a biocompatible polymer and all trans retinoic acid (ATRA), or its derivatives, can be used to treat, prevent, or inhibit thrombosis and / or neointimal hyperplasia which may otherwise be induced by prosthetic implantation. In particular, the implants herein can inhibit smooth muscle cell proliferation, neointimal hyperplasia, and upregulate antithrombotic genes and nitric oxide production in the vasculature. Further, the implants are capable of delivering controlled and predictable localized concentrations of ATRA.
Owner:VESSELTEK BIOMEDICAL

Biotinylated-chemokine antibody complexes

Biotinylated pharmacologically active agents and complexes containing same are disclosed. In particular, biotinylated-chemokines are described. The complexes further include an anti-biotin antibody that selectively binds to biotin. The complex can be dissociated by contact with free biotin. The complexes are particularly useful for enhancing an immune response to tumor cells and virus-infected cells, in vivo or in vitro.
Owner:MILLENNIUM PHARMA INC

Support apparatus for preventing and/or inhibiting decubitus ulcers

ActiveUS20130160208A1Preventing and inhibitingPreventing and/or inhibiting decubitus ulcersNursing bedsRigid tablesRecumbent PositionEngineering
An apparatus and method for preventing decubitus ulcerations including a frame having a pair of frame supports spaced from each other. A mattress is supported on the frame between the frame supports. A pliable support material extends between the supports. The material is adapted to support an individual thereon in a generally recumbent position. A lift mechanism is disposed on the frame and operably connected to the support material. The lift mechanism adjusts the tension of the material so that the support has a first position resting on the mattress and a second position wherein the support is raised above the mattress.
Owner:DAVENPORT THOMAS +1

Medicine feeding apparatus

ActiveUS20050115634A1Reduces kinetic energyDischarge medicineLiquid fillingSolid materialDrugKinetic energy
An object of the invention is to provide a medicine feeding apparatus in which it is possible to prevent a medicine from being broken by well absorbing and reducing a kinetic energy at a time of discharging the medicine even in the case that a downsizing and a densification are promoted for making a discharge speed of the medicine higher, and it is possible to efficiently guide the medicine to an outlet portion of a hopper. Further, the medicine feeding apparatus is provided with a main body, a plurality of tablet cases receiving medicines, a chute received in the main body and through which the medicine discharged from the tablet case comes down, a hopper received in the main body, provided in correspondence to a lower side of the chute and collecting the medicines, and a filling apparatus received in the main body and filling the medicines collected by the hopper in a drug packing paper or a container. The hopper has a curtain for preventing the medicine passing through the chute from jumping up or rotating in the hopper caused by drop and absorbing a kinetic energy.
Owner:PHC HLDG CORP

Antibodies to a tumor-associated surface antigen for delivery of diagnostic and therapeutic agents

The present invention relates to the treatment, inhibition and prevention of cancer by the administration of anti-C3b(i) antibodies. The invention also relates to the treatment, inhibition and prevention of cancer by the administration of IgM antibodies and / or complement components prior to the administration of anti-C3b(i) antibodies. The present invention further relates to the detection, imaging, diagnosis and monitoring of cancer utilizing C3b(i) specific antibodies.
Owner:UNIV OF VIRGINIA ALUMNI PATENTS FOUND

Catheter having a reinforcing mandrel

A catheter having a mandrel secured to the catheter or constrained within a dedicated lumen. In one embodiment, the catheter has an inner tubular member and an outer tubular member with a sidewall configured to define a mandrel lumen longitudinally along an inner surface of the outer tubular member or along an outer surface of the inner tubular member. The mandrel lumen may be configured to allow the mandrel to be exchanged to adjust the handling characteristics of the catheter. The mandrel may occupy an intermediate portion of the catheter shaft, or may extend from the proximal end to within proximal or distal shaft sections of the catheter. In coronary artery applications, the mandrel is configured to support the catheter as it bends through the aortic arch and enters the coronary artery.
Owner:ABBOTT CARDIOVASCULAR

5-Morpholinylmethylthiophenyl Pharmaceutical Compounds As P38 MAP Kinase Modulators

InactiveUS20070208015A1Treatment or prophylaxis of cancersPrevent and inhibitAntibacterial agentsOrganic active ingredientsArylHalogen
The invention provides compounds of the formula (I) or a salt, solvate or N-oxide thereof, wherein: R1 and R2 are the same or different and each is selected from hydrogen, saturated C1-3 hydrocarbyl, halogen and cyano; X is selected from C═O, C═S, C(═O)NH, C(═S)NH, C(═O)O, C(═O)S, C(═S)O and C(═S)S; R3 is selected from aryl and heteroaryl groups each having from 5 to 12 ring members and being unsubstituted or substituted by one or more substituent groups R10 as defined in the claims; R4 and R5 are the same or different and are selected from hydrogen and methyl; or one of R4 and R5 is selected from hydroxymethyl and ethyl and the other is hydrogen; and R6 and R7 are the same or different and are selected from hydrogen and methyl. The compounds of the formula (I) hayed activity as p38 MAP kinase and Taf kinase inhibitors.
Owner:ASTEX THERAPEUTICS LTD

Wafer transport apparatus

The wafer transport apparatus prevents contaminant deposited on an unprocessed wafer from adhering to a processed wafer. Carrying-in load port 2A is loaded with a FOUP 1 storing an unprocessed wafer W1. Carrying-in chamber 3A has a transport robot 4A which takes out the unprocessed wafer W1 from the FOUP 1. Carrying-in load lock 5A is accessed by the transport robot 4A from the carrying-in chamber 3A side. Carrying-out load port 2B is loaded with the FOUP 1 that can store a processed wafer W2. Carrying-out chamber 3B has a transport robot 4B which passes the processed wafer W2 to the FOUP 1. Carrying-out load lock 5B is accessed by the transport robot 4B from the carrying-out chamber 3B side. The carrying-in chamber 3A and carrying-out chamber 3B are separated from each other. The carrying-in load lock 5A and carrying-out load lock 5B are arranged on different stages.
Owner:SINFONIA TECHNOLOGY CO LTD

Rotatable brush for surface cleaning apparatus

A surface cleaning apparatus includes a rotatably mounted brush associated with a dirty air inlet. A plurality of bristles extend outwardly from a radial outer surface of the rotatably mounted brush. A heating element that is positioned exterior to the brush core.
Owner:OMACHRON INTPROP

Cutter and printer with cutter

InactiveUS20100221055A1Ease of use be particularly goodPrevent or inhibitOther printing apparatusMetal working apparatusEngineeringKnife cuts
A printer with a cutter is provided that can discharge cut-offs in a stable condition. A printer includes a transportation path, a transportation mechanism that conveys a recording medium along the transportation path, a fixed knife having a cutting edge, a movable knife having a cutting edge and moving between a standby position and a cutting-completed position, and an exit disposed along the transportation path. The exit includes a narrow opening defined by a first elongated side offset from the transportation path beyond the movable-knife cutting edge in the cutting-completed position, and a second elongated side opposite the first elongated side and offset from the transportation path opposite to the first elongated side. The second elongated side can be located immediately adjacent to the transportation path, for example, by less than or equal to 2 mm.
Owner:SEIKO EPSON CORP

Methods and apparatuses for inhibiting rotational misalignment of assemblies in expandable well tools

A gripper for use in a downhole tool is provided. The gripper can include an actuator, an engagement assembly, and an expandable assembly. The engagement assembly can comprise a leaf-spring like elongate continuous beam. The expandable assembly can comprise a linkage including a plurality of links. The linkage can be coupled to the actuator such that the actuator expands the expandable assembly which in turn expands the engagement assembly. One or more keyed connections can inhibit rotational misalignment of the expandable assembly from the engagement assembly. In operation, during one stage of expansion radial forces are transmitted to the engagement assembly through both interaction of a rolling mechanism on the engagement assembly with the expandable assembly and pressure of the linkage assembly directly on an inner surface of the engagement assembly. The one or more keyed connections can preferably facilitate full retraction of the expandable and engagement assemblies.
Owner:WWT NORTH AMERICA HLDG

Bioactive agents under water dispersible solid forms for food, nutraceutical, agricultural and pharmaceutical applications

The present document describes a powder composition comprising a functionalized starch having a single helix V-structure and having a degree of substitution of at least 0.25, and a bioactive agent, forming an inclusion complex with said functionalized starch, where the bioactive agent is within the helix V-structure of the functionalized starch having a single helix V-structure. Also described are the functionalized starch having a single helix V-structure and having a degree of substitution of at least 0.25, methods of making the same and methods of using the same to manufacture the powder composition.
Owner:B ORGANIC FILMS
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products